Inrecentyears,theconsumptiontrendofprobioticproductshasbeenincreasingdaybyday,andtheindustrydevelopmenthasenteredaboomperiod.Accordingtosurveydata,theoutputvalueoftheglobalprobioticindustryisexpectedtoexceedUS$77billionin2025.WecareProbioticshasbeenendeavoringfortenyearstodeeplyexplorethefieldofprob

Abstract:ThisstudyintroducesanovelprobioticstrainofLactiplantibacillusplantarumCW006,withsignificantantihypertensiveproperties.Thestrain'sabilitytoproduceproductsthatlowerbloodpressureofferspromisingapplicationsinfoodprocessingandthepharmaceuticalindustry.Theresearchexploresthestrain'smechan

Akkermansiamuciniphila(AKK),oftenreferredtoasthe“longevityprobiotic,”hasgarneredincreasingattentionforitspromisingroleinpromotinghealthyaging.Recentstudieshavehighlightedhowthisuniquegutmicrobeinfluencesmultiplemarkersofaging,contributingtobettermetabolichealth,immuneregulation,andoverallvitality.As

Chronickidneydisease(CKD)isasignificanthealthproblemthataffectsmillionsofindividualsglobally.Theneedforeffectivetherapeuticagentshasledtotheexplorationofprobioticsasapotentialtreatment.ThisjournalfocusesonaspecificprobioticagentdesignedtoimproveCKD,itscomposition,anditsapplications,asdescribedinthep

IntroductionThispatentdelvesintothedetailedexaminationoftheAkkermansiamuciniphilaAkk007,aprobioticwithsignificantimmunomodulatoryproperties.Thestrainhasshownpromiseinenhancingimmunefunctionandisproposedforvariousapplicationsinhealthsupplementsandfunctionalfoods.Characteristics:Akkermansiamuciniphila

RecentgroundbreakingresearchpublishedinNatureMicrobiologyhashighlightedthesignificantroleofAkkermansiamuciniphila(Akk)incombatingmetabolicdisorders.Thisrevelationcomesatacrucialtimewhenmetabolicdiseasessuchastype2diabetes,non-alcoholicfattyliverdisease,andmetabolicsyndromearerisingglobally.Thesecond